1481226

Związek pokrewny oksaliplatyny B

United States Pharmacopeia (USP) Reference Standard

• Synonim(y): [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-N,N′)dinitratoplatinum(II)
• Wzór empiryczny (zapis Hilla): C₆H₁₄N₄O₆Pt
• Numer CAS: 66900-68-3
• Masa cząsteczkowa: 433.28
• MDL number: MFCD28137839
• UNSPSC Code: 41116107
• NACRES: NA.24

Właściwości

• grade: pharmaceutical primary standard
• agency: USP
• API family: oxaliplatin
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule); pharmaceutical
• format: neat
• SMILES string: [Pt+4].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N-H]C1C(CCCC1)[N-H]
• InChI: 1S/C6H12N2.2NO3.Pt/c7-5-3-1-2-4-6(5)8;2*2-1(3)4;/h5-8H,1-4H2;;;/q-2;2*-1;+4
• InChI key: IXGZKDPDRONRDI-UHFFFAOYSA-N

Opis

General description

Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Oxaliplatin Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:

• Oxaliplatin
• Oxaliplatin for Injection
• Oxaliplatin Injection

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Klasa składowania: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable